Treatment Of Solid Tumours With Rapamycin Derivatives

Patent No. EP2269603 (titled "Treatment Of Solid Tumours With Rapamycin Derivatives") was filed by Novartis on Feb 18, 2002. The application was issued on May 20, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2269603

NOVARTIS
Application Number
EP10174983A
Filing Date
Feb 18, 2002
Status
Revoked
Nov 15, 2019
Publication Date
May 20, 2015